Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency and affect recognition functions
Mihály Józsi(Eötvös Loránd University), Christine Skerka(OncoMed (United States)), Barbara Uzonyi(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Peter F. Zipfel(Systems Analytics (United States)), Svante Zipfel(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Matthew Edey(Newcastle University), Lisa Strain(Newcastle upon Tyne Hospitals NHS Foundation Trust), Christoph Licht(University of Toronto), Heiko Richter(Max Planck Institute for Innovation and Competition), Anne E. Hughes(Queen's University Belfast), Judith A. Goodship(Newcastle University), Danny Routledge(Newcastle upon Tyne Hospitals NHS Foundation Trust), Timothy H.J. Goodship(Newcastle University), Stefan Heinen(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI))
Cited by 5
Related Papers
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.
|Journal of Medical Genetics|1997|1.2k
Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination
|Nature Genetics|2003|643
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361